Isodiol International

Global Leader in Hemp-Derived Cannabinoids

This profile is part of a paid investor education campaign.*

Overview

Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), specializes in the development of pharmaceutical and health and wellness products and is now supporting the pharmaceutical industry at large with its recently approved CBD as an Active Pharmaceutical Ingredient.

Isodiol International Inc. is focused on the nutritional health benefits that are derived from hemp and is a product development, sales, marketing and distribution company of hemp-based consumer products and solutions. The company specializes in identifying emerging trends and opportunities from all Cannabinoids available in hemp.  Through the development of its own IP, Isodiol has been able to create a portfolio of products which are sold through various channels domestically in the US, and internationally.

Isodiol has the commercialized a 99%+ pure, naturally isolated CBD, including micro-encapsulations, and nano-technology for quality consumable and topical skin care products. Most recently, the company received approval for its CBD designated as an Active Pharmaceutical Ingredient for use in Finished Pharmaceutical Products as was announced April 26, 2018. This approval was obtained by the Medicines and Healthcare products Regulatory Agency of the UK.

The Company’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its phytoceutical portfolio and will aggressively continue International expansion into Latin America, Asia and Europe.

The following lists the company’s subsidiaries and includes a description of each subsidiary’s key activities:

C3 Global Biosciences (C3GBS)

C3GBS’s business is focused on CBD research, science, innovation and technology to positively impact patient outcomes through clinical studies and evidence-based empirical data gathered by validated devices and platforms. Along with Isodiol, C3GBS will continue to focus on the research and development of CBD and other cannabinoids to improve the quality of life for consumers. Both the Company and C3GBS will continue to focus on the utilization of the Electroencephalogram (EEG) technology in the phytoceutical field, which allows physicians and researchers real-time feedback on the effect of Cannabis products.

The Bradley’s Brand (Bradley’s Brand)

Bradley’s Brand’s business is focused on manufacturing and distributing hemp oil and nicotine eliquids, as well as personal care products. Bradley’s Brand also offers apparel and merchandising solutions. By partnering with Isodiol, Bradley’s has been able to increase its operational reach from the United States and the United Kingdom, to the Latin American and additional European markets.

ISO-Sport

ISO-Sport’s business is to create products to focused on enhancing athletic performance and recovery needs of professional and prosumer athletes. The hemp-based nutrition line is geared towards mental and body wellness. ISO-Sport has been focused on raising awareness of CBD and related benefits that have been used by individuals within athletic organizations such as the National Football League, Cage Warriors and the MMA. ISO-Sport will continue to focus efforts towards professional athletes with the goal of assisting athletes through their daily lives, training and recovery process. This is a whollyowned division of Isodiol International Inc.

Iso-Bev

Iso-Bev is in the manufacturing and development of consumer beverages derived from hemp. The Company hopes to take advantage of the hemp infused beverage industry with Iso-Bev’s monthly bottling capacity which is able to produce up to 5,000,000 bottles per month. This is a wholly-owned subsidiary of Isodiol International Inc. IsoBev, acquired 100% of the assets of Culinary Coffee Roasters who’s business is the sale of quality coffees, tea and blended formulations, based out of Stuart, Florida. Culinary has been in the coffee beverage business for over fifteen years.

Isolabs International Inc.

This division focuses on phytoceutical development in North America and International markets with development of IP and other proprietary assets This division will continue to externally source the cultivation of the plant and bring the manufacturing, processing, product R&D and distribution inhouse.

Biosynthesis Pharma Group Laboratories Ltd. (BSPG) BSPG is large producer of industrial hemp and was the first Company to receive MHRA approval as an Active Pharmaceutical Ingredients (API) license holder. Through BSPG’s industrial-sized, proprietary extraction methodologies, BSPG produces high-purity, bioactive cannabinoids that are used in pharmaceutical applications to benefit those suffering from a range of life-threatening and non-lifethreatening illnesses. BSPG is currently conducting clinical trials involving its product through strategic partnerships around the globe. Pursuant to the BSPG acquisition, the Company also acquired 99% of the assets of Purodiol do Brasil Ltda. which consists of Purodiol trademarks and retention of the previous CEO of Purodiol who contains key product manufacturing and market knowhow.

KURE™ Corp. (KURE)

KURE is a wholly owned subsidiary of Isodiol International Inc., headquartered in Charlotte, North Carolina and specializes in the distribution of vaporizing pens, e-Juices, and related accessories through its specialty retail stores and online distribution. KURE’s primary products are its distinct line of custom blended flavored e-Juices, KURE brand vaporizers, as well as popular third-party brands of advanced hardware and select eLiquids. All KURE products are available online and throughout its many store locations across the United States. KURE Vaporium™, KURE Society™, Kuriousity™, Kurators™, KURE Vape Pod are all respective trademarks of KURE.

Azure Bottling LLC (Azure)

Azure is a custom bottled water facility which is FDA approved and complies with local and state guidelines. They provide spring water, purified water, mineral water, vitamin-enhanced and alkaline water which is free of contaminants and impurities.

CBD Product Supplier with a Global Reach

Bulk Products:

  • Cannabinoid extracts that include crystalline, oils and concentrates.
  • Target markets include chemical distributors, pharmaceuticals, cosmetics and retail.

Pharmaceutical products:

  • Topical and over-the-counter products including the Rapid Patch, Rapid Cream and ISODERM™, which used advanced patented technology and offers the most effective form of CBD available in the marketplace.
  • Target markets include pharmaceuticals and health care providers.

Consumer Products:

  • Isodiol, which produces bulk products derived from hemp and designs its own line of ingredient technologies and finished products.
  • IsoSport™ provides hemp-based health and fitness products aimed at supporting the unique performance needs of athletes.
  • Pot-O-Coffee™ brand of coffee, tea and hot cocoa infused with cannabis extracts in both K-Cup™ and ready-to-drink form. Isodiol has signed a definitive licensing agreement with Canopy Growth Corp for the retail distribution of these products.
  • CannCeuticals luxury skincare brand specializing in anti-aging formulas that use micron-encapsulated CBD™.
  • Target markets include nutraceuticals and retail.

Non-Cannabis CBD Products

Isodiol has also developed a line of ImmunAG™ products, which host a completely natural herbal complex designed to help support the endocannabinoid system. This line of products are THC-free and may play a role in addressing age-related cognitive functions, control stress and anxiety, and body discomfort.

Partnerships and Licensing Agreements

As a component of their growth strategy, Isodiol has embarked on a number of licensing agreements with companies in the medical and cannabis spaces. The first of these was the licensing agreement with Canopy Growers Corp for the distribution of products under the Pot-O-Coffee™ brand.

Since the start of 2018, the company has entered into multiple other agreements that support the development of Isodiol as a whole and the production and distributions of its products. A sample of these agreements are described below.

In early January, the company entered into a 10-year licensing agreement Level Brands Inc, an innovative marketing and brand development firm. Within the agreement, Isodiol and Level Brands are developing consumer products under the lifestyle and wellness brands led by Level’s Chairman Emeritus Kathy Ireland, kathy ireland® Health & Wellness and Ireland Men One. As part of this agreement, the companies launched three new CBD product categories: CBD oral sprays, CBD pain-relieving cream and CBD edibles.

Only a few days later, the company released a statement regarding a supply agreement with Namaste Technologies Inc, an online retailer for cannabis delivery systems globally. Under this agreement, Isodiol will be a provider of phytoceutical products to Namaste and these products will be sold through select distribution channels on the e-commerce platform.

Isodiol also announced a licensing agreement with Livecare Health Canada Inc, a group dedicated to providing patients with access to real-time medical care through the use of their Telehealth Platform. Under the agreement, Isodiol with license Livecare’s platform for all cannabis, cannabis-derived, cannabinoid and phytoceutical products and related services, for which it will pay a royalty fee. Livecare has committed to customize the platform to this effect and will assist with its marketing and deployment.

“Isodiol is extremely proud of this innovative step, where our consumers will now have the ability to consult with medical experts via the Telehealth Platform technology,” said Agramont.

In April and May 2018, the company signed letters of intent with Agrima Botanicals and Zenabis, respectively, to supply 99.5 percent pharma-grade CBD from its GMP-certified production facility in the UK. Under the proposed agreements, Agrima would inport up to 5,000 grams of CBD isolate per month for R&D purposes and Zenabis, a Canadian licensed producer, would import 3,000 grams per month for the same purpose.

In May 2018, Isodiol announced a binding agreement to acquire 51 percent of Farmtiva LLC, a California-based hemp cultivator that also provides farming and distribution support to farmers and industry participants. In partnership with the Imperial Valley Conservation Research Center, Farmtiva will be planting the first California hemp crop in mid 2018.

Subsidiaries

C3 Global Biosciences (C3GBS)

C3GBS’s business is focused on CBD research, science, innovation and technology to positively impact patient outcomes through clinical studies and evidence-based empirical data gathered by validated devices and platforms. Along with Isodiol, C3GBS will continue to focus on the research and development of CBD and other cannabinoids to improve the quality of life for consumers. Both the Company and C3GBS will continue to focus on the utilization of the Electroencephalogram (EEG) technology in the phytoceutical field, which allows physicians and researchers real-time feedback on the effect of Cannabis products.

The Bradley’s Brand (Bradley’s Brand)

Bradley’s Brand’s business is focused on manufacturing and distributing hemp oil and nicotine eliquids, as well as personal care products. Bradley’s Brand also offers apparel and merchandising solutions. By partnering with Isodiol, Bradley’s has been able to increase its operational reach from the United States and the United Kingdom, to the Latin American and additional European markets.

ISO-Sport

ISO-Sport’s business is to create products to focused on enhancing athletic performance and recovery needs of professional and prosumer athletes. The hemp-based nutrition line is geared towards mental and body wellness. ISO-Sport has been focused on raising awareness of CBD and related benefits that have been used by individuals within athletic organizations such as the National Football League, Cage Warriors and the MMA. ISO-Sport will continue to focus efforts towards professional athletes with the goal of assisting athletes through their daily lives, training and recovery process. This is a whollyowned division of Isodiol International Inc.

Iso-Bev

Iso-Bev is in the manufacturing and development of consumer beverages derived from hemp. The Company hopes to take advantage of the hemp infused beverage industry with Iso-Bev’s monthly bottling capacity which is able to produce up to 5,000,000 bottles per month. This is a wholly-owned subsidiary of Isodiol International Inc. IsoBev, acquired 100% of the assets of Culinary Coffee Roasters who’s business is the sale of quality coffees, tea and blended formulations, based out of Stuart, Florida. Culinary has been in the coffee beverage business for over fifteen years.

Isolabs International Inc.

This division focuses on phytoceutical development in North America and International markets with development of IP and other proprietary assets This division will continue to externally source the cultivation of the plant and bring the manufacturing, processing, product R&D and distribution inhouse.

Biosynthesis Pharma Group Laboratories Ltd. (BSPG) BSPG is large producer of industrial hemp and was the first Company to receive MHRA approval as an Active Pharmaceutical Ingredients (API) license holder. Through BSPG’s industrial-sized, proprietary extraction methodologies, BSPG produces high-purity, bioactive cannabinoids that are used in pharmaceutical applications to benefit those suffering from a range of life-threatening and non-lifethreatening illnesses. BSPG is currently conducting clinical trials involving its product through strategic partnerships around the globe. Pursuant to the BSPG acquisition, the Company also acquired 99% of the assets of Purodiol do Brasil Ltda. which consists of Purodiol trademarks and retention of the previous CEO of Purodiol who contains key product manufacturing and market knowhow.

KURE™ Corp. (KURE)

KURE is a wholly owned subsidiary of Isodiol International Inc., headquartered in Charlotte, North Carolina and specializes in the distribution of vaporizing pens, e-Juices, and related accessories through its specialty retail stores and online distribution. KURE’s primary products are its distinct line of custom blended flavored e-Juices, KURE brand vaporizers, as well as popular third-party brands of advanced hardware and select eLiquids. All KURE products are available online and throughout its many store locations across the United States. KURE Vaporium™, KURE Society™, Kuriousity™, Kurators™, KURE Vape Pod are all respective trademarks of KURE.

Azure Bottling LLC (Azure)

Azure is a custom bottled water facility which is FDA approved and complies with local and state guidelines. They provide spring water, purified water, mineral water, vitamin-enhanced and alkaline water which is free of contaminants and impurities.

Summary of Investment Highlights

  • Expanded presence worldwide, particularly across the Americas, the UK and Australia and New Zealand
  • Distribution Channels in North America, Latin America, South America, Europe, including mainstream channels such as FARMA USA (Brazil), Threshold Enterprises, and United Natural Foods (UNFI).
  • Signed Definitive Licensing Agreement with Canopy Growth Corporation (WEED:CA) for Company’s Pot-O-Coffee and Pot-O-Tea.
  • Brazilian Health Regulatory Agency (ANVISA) approval of ISODERM™ and ISODIOLEX™, enabling both to be prescribed by doctors and neurologists for the treatment of Epilepsy and Parkinson’s Disease.
  • Acquired 99% of Purodiol Do Brasil Ltda (PUR-Brazil). PUR-Brazil supplies Purodiol pharmaceutical products under ANVISA regulations and is currently involved in multiple clinical studies and trials.
  • Announced product placement of Pot-O-Coffee and Pot-O-Tea in select WinnDixie stores throughout East Coast.
  • Signed Licensing Agreement with Level Brands Inc, where the companies will work to develop and market consumer products for subsidiaries Kathy Ireland Health & Wellness and Ireland Men One (I’M1).
  • Signed a Licensing Agreement with Livecare Health Canada Inc, granting Isodiol the exclusive right to use Livecare’s Telehealth Platform relating to all cannabis, cannabis-derived, cannabinoid and phytoceutical products.
  • Announced Partnership with Europe’s leading MMA promoter, Cage Warriors, through its brand Iso-Sport™.
  • Reported unaudited Q3 revenues for the period ended December 31, 2017 of $5.89 million CDN for net operational profit of $202,254 CDN – a 16% increase from Q2.
  • Completed acquisition of Biosynthesis Pharma Group Limited (“BSPG”) in the UK. BSPG is actively involved in multiple clinical trials and studies globally and produces an MHRA approved Active Pharmaceutical Ingredient (API) CBD Molecule for use in pharmaceutical applications.
  • Signed Letter of Intent to acquire 100% of leading specialty vape retailer KURE Corp, a company with unaudited fiscal 2018 revenue of 8.8 million USD.
  • Signed Definitive Agreement to acquire premier bottling facility, Azure Bottling LLC, with full capacity running approximately 5.3 million bottles per month.
  • Announced further international expansion in Latin America with Scythian Biosciences Corp for distribution in Argentina, Jamaica, and Columbia.
  • Commenced development of a new state-of-the-art processing facility in Yunnan, China that will process over 15 metric ton of hemp biomass daily for the extraction of cannabinoids and terpenes for use in medical, nutraceutical, food and cosmetic industries.
  • Signed Definitive Agreement to acquire a 19.9% equity stake in Compass Cannabis Clinic and obtained exclusive CBD distribution rights for its family of brands through the Compass distribution network.
  • The Company’s wholly owned subsidiary BSPG Laboratories, LTD. has received government approval from United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA), in accordance with The Human Medicines Regulations 2012 (SI 2012/1916), for the manufacturing of the active substance Cannabidiol (CBD) under certificate number: UK API

Management

Marcos Agramont – Director, CEO

Marcos Agramont has been a leading innovator in the Cannabis Industry for the last five years developing products for domestic and international channels. He has pioneered delivery systems, regulations and processes for major brands in order to meet safety standards and compliance. He was instrumental in implementing innovative delivery apparatuses with concise servings, at a time when no accurate measuring of dosage for general usage existed.

He has helped introduce CBD to the pharmaceutical global markets including Japan, Latin America, the European Union and Australia. He intends to make a continued contribution to the industry by joining Isodiol and will help bring the Company and its family of brands to the forefront of Cannabis Bioscience and CBD Pharmaceuticals.

Marvin Washington — Director, VP of Business Development 

Mr. Washington is a graduate of Idaho University and a 2004 inductee into the University of Idaho Vandal Sports Hall of Fame. After football Mr. Washington worked for William Small Wealth Management Group as a Financial Advisor. Mr. Washington worked in financial services for 10 years focusing on financial planning, retirement planning and estate planning.

Now a serial entrepreneur, Mr. Washington is focused on the cannabis industry. He is an investor and co-owner of a number of cannabis ventures. Mr. Washington is also a NFL league ambassador for Athletes For Care and is a member of the Board of Directors. Mr. Washington has been instrumental in starting discussion with the NFL Players Association for changes in the sport’s drug policies.

Eli Dusenbury – Chief Financial Officer

Mr. Dusenbury has over 8 years of public accounting experience providing financial reporting, operational and assurance engagement services to a variety of both public and private sector entities reporting in Canada and the US. With working experiences in both Canada and the US over a wide range of public and private companies, Mr. Dusenbury has gained in-depth understanding of business operations, control environments and strategic business decision-making, which provide a unique balance between both operational and accounting perspectives to resolve complex technical accounting, reporting and auditing issues.

Patrick Ogle – Chief Operating Officer

Mr. Ogle is a seasoned general counsel to public companies and has co-founded and operated private businesses in the beverage, staffing, apparel, and mining industries throughout the past twenty years.  He began his legal career as a federal judicial law clerk and as an associate in the investment management and capital markets practice groups at a renowned law firm in Washington, D.C. and New York City.

Troy Nihart – President

Troy Nihart has over 20 years of business development and entrepreneurship experience and has been an integral part of the CBD industry over the last 4 years. He has been instrumental in the development of an international supply chain for the US Market of hemp derived CBD and has developed some of the most recognized brands in the cannabis industry.

Aman Parmar – Chairman

Aman Parmar’s corporate experience includes twelve years working with both public and private companies in the Health Care, Resource, Manufacturing and Real Estate sectors. He has extensive experience in the capital markets and has been involved in corporate restructurings and financings for both public and private companies. He obtained a Chartered Accountant designation in 2012 and holds a Bachelor of Technology in Accounting from the British Columbia Institute of Technology.


 

*Disclaimer: The profile provides information which was sourced and approved by Isodiol International in order to help investors learn more about the company. Isodiol International is a client of the Investing News Network (INN). The company’s campaign fees pay for INN to create and update this profile page, to which links are placed on Investingnews.com and channel newsletters.

The company description, investment highlights and catalysts were sourced by INN and approved by the company. INN does not guarantee the accuracy or thoroughness of the information contained on this page.

INN does not provide investment advice and the information on Investingnews.com profile should not be considered a recommendation to buy or sell any security.

INN does not endorse or recommend the business, products, services or securities of any company profiled.

Readers should conduct their own research for all information publicly available concerning the company.